原发性高血压病患者颈动脉粥样硬化程度与血清胆红素水平的相关性研究

目的 探讨高血压病患者颈动脉粥样硬化程度与血清胆红素水平的关系.方法 158 例高血压病患者行双侧颈动脉超声多普勒检查,根据检测结果分为颈动脉粥样硬化组和正常颈动脉组.记录各组年龄、性别、体重指数、吸烟史、糖尿病史和血压,测定血清总胆红素及其他生物化学指标.结果 颈动脉粥样硬化组的血清总胆红素水平(8.37±3.53)μmol/L显著低于正常颈动脉组(14.53±4.61)μmol/L(P＜0.05).多因素回归分析显示低胆红素血症与颈动脉粥样硬化呈显著正相关(χ2wald=4.41,P=0.029,OR=3.72).结论 低胆红素血症是高血压病患者发生颈动脉粥样硬化的独立危险因素.     

大鼠气管上皮细胞体内—体外转化模型的研究

本研究建立了大鼠气管上皮细胞体内－体外转化模型，大鼠气管内滴注苯并芘，三天后处死大鼠，消化气管上皮细胞，接种于无血清完全培养基。细胞形成集落后，换为选择培养基继续培养五周，统计转化率。结果显示，２５ｍｇ／ｋｇ和５０ｍｇ／ｋｇ的苯并芘可诱导大鼠气管上皮细胞转化及微核增加，用同样方法研究了煤焦沥青提取物，结果表明，剂量为８ｍｇ／ｋｇ和２５ｍｇ／ｋｇ的煤焦沥青提取物能明显诱导大鼠气管上皮细胞转化。     

庆大霉素经乳汁的排泄

采用荧光偏振免疫法测定１４例剖宫产术后应用肌注或静点庆大霉素的产妇乳汁及血清中庆大霉素的浓度，结果表明肌注或静点庆大霉素后３￣５小时，乳汁中浓度达峰值，血清中庆大霉素的浓度于给药后０．５小时达峰值。提示：无论肌注或静脉给庆大霉素均可经乳汁排泄，乳母不宜应用庆大霉素，即使产后已应用庆大霉素，应停药１３小时后方可哺乳。     

血清磷、肌酸激酶及其同工酶的测定在肠梗阻诊断中的应用

肠梗阻是临床常见的急腹症，绞窄性肠梗阻的死亡率可高达４５％～３０％，我们自１９９５年８月至１９９７年４月共收治肠梗阻５３例，其中单纯性肠梗阻２８例，经手术证实为绞窄性肠梗阻２５例（其中肠坏死８例），在治疗前均测定血清磷、肌酸激酶及其同工酶，其结果：本组病例中血清磷升高者１４例，其中以８例肠坏死为显著，肌酸激酶及其同功酶的升高也以绞窄性肠梗阻为明显，其中又以发病时间在４８小时以内者和８例肠坏死者为著，因此，我们认为：血清磷、肌酸激酶及其同工酶的测定可以作为判断肠管是否发生绞窄及坏死的辅助诊断指标     

银屑病患者血清促进皮肤成纤维细胞增生的实验研究

进行期寻常型银屑病患者混合血清以5%的比例加入培养基中,作用于体外培养的正常人皮肤成纤维细胞.结果发现,对该细胞的增生具有明显的促进作用.提示银屑病不仅是表皮细胞的异常增生,真皮成纤维细胞的异常和系统性因素在其病理生理方面也占有重要地位.     

Sialic acid concentrations in the urine of men with and without renal stones

Summary It has been suggested that urinary sialidase may play a role in the formation of renal stones. The present study was therefore undertaken to compare spectrophotometrically the different types of sialic acid concentrations and sialidase activities in fresh first morning urine specimens of men (21–65 years) with (13) and without (9) calcium oxalate renal stones. Although the free urinary sialic acid concentrations of the two groups of men were statistically about the same (P=0.0614), the total (P=0.003) and bound (P=0.0012) urinary sialic acid concentrations differed significantly. Both the total and bound sialic acid concentrations were lower in the urine specimens of the stone patients than in their healthy counterparts. This decrease in urinary sialic acid concentrations was firstly thought to be the result of elevated breakdown enzymes of sialic acid, which would favour the production of pyruvate. However, spectrophotometric determinations of the endogenous pyruvate concentrations of the two types of urine specimens did not differ significantly (P=0.0708). Secondly, the decrease in total urinary total sialic acid concentration of stone patients, could be attributed to less sialic acid synthesis or less renal excretion. Therefore, the same experiments were repeated using serum of 13 patients and 9 healthy men. Conversely, the total (P=0.4425) and bound (P=0.2850) serum sialic acid concentrations were found to be similar in the two types of subjects. However, the free serum sialic acid concentration of stone patients was significantly lower than in the healthy subjects (P=0.0062). This phenomenon is also reflected in the average ratio for serum free: bound sialic acid in healthy and stone patients, 1:7.9 and 1:18.7 respectively (P=0.0009). The lower free serum sialic acid concentration may lead to lower renal excretions of sialic acid. This may explain the decrease in total urinary sialic acid concentration in stone patients. The lower bound urinary sialic acid concentrations in patients was also reflected in the urinary free: bound sialic acid ratio for healthy (1:2.3) and stone patients (1:1.3). The difference between these two groups of men was highly significant (P=0.0001). This phenomenon might be explained by the urinary sialidase activities, which was spectrophotometrically determined at 334 nm at 37°C of 11 patients with stones and 17 healthy men. The ages of both groups of men were the same (P=0.326). An increase in urinary sialidase activity was observed with the stone patients (P=0.00001) when compared to specimens of healthy men. This might explain the decrease in urinary bound sialic acid concentration of the stone group. It seems from these results that the urinary concentration of sialic acid and the activity of urinary sialidase, may play a role in the pathogenesis of the multifactorial disease, urolithiasis.     

子宫肌瘤患者外周静脉与子宫静脉血管内皮细胞生长因子水平测定及临床意义

目的:探讨血管内皮细胞生长因子(VEGF)在子宫肌瘤发生和肌瘤生长中的作用。方法:手术中暴露子宫静脉后,抽取子宫静脉血3ml,同时抽取非输液肢体外周静脉血3ml。抽取配对正常妇女外周静脉血3ml。ELISA法测定VEGF水平。测量子宫重量、肌瘤总重量、肌瘤数目和最大肌瘤最大径线值。结果:子宫肌瘤患者子宫静脉血和外周静脉血VEGF水平分别为159.38±25.63pg/ml和76.35±26.61pg/ml,对照人群外周静脉血VEGF水平为42.53±29.47pg/ml。子宫静脉血中的VEGF水平明显高于外周静脉血(P=0.019),子宫肌瘤患者外周静脉血中的VEGF水平明显高于对照人群外周静脉血的VEGF水平(P=0.013)。子宫重量、肌瘤总重量、肌瘤数目、最大肌瘤最大径线都与子宫肌瘤患者子宫静脉和外周静脉VEGF呈显著正相关。结论:VEGF可能参与了子宫肌瘤的生长和病情发展。     

体外反搏治疗血清对培养内皮细胞基因表达的影响

目的探讨经体外反搏治疗的冠心病患者血清对血管内皮细胞基因表达的调控效应。方法分别取接受体外反搏治疗的冠心病患者1、24和36h时间点的血清，用于培养人脐静脉血管内皮细胞。用cDNA基因芯片检测3个治疗时点反搏前、后血管内皮细胞基因表达谱。结果反搏前后比较，有10个基因（核转录因子、真核转录启动因子-4、平滑肌的肌球蛋白重链、α2-肌动蛋白、微管蛋白β肽链、组织相容蛋白G、黑色素黏附分子、神经介素B受体、蛋白激酶4K2、血小板凝血酶敏感蛋白-1）的表达在3个治疗时点上出现显著改变。在1h点均为上调，在24h、36h时点均为下调。结论体外反搏治疗冠心病患者血清对血管内皮细胞的炎症反应、细胞凋亡相关基因表达有调效应，并随体外反搏治疗时间的增加早抑制其表达的趋势。     

Naturally occuring antibodies against nerve growth factor in human and rabbit sera: comparison between control and herpes simplex virus-infected patients

Antibodies against nerve growth factor (NGF) in sera were detected by enzyme-linked immunosorbent assays (ELISA), by their isolation after passage of sera through NGF immunoadsorbent columns and by their specificity to bind and immunoprecipitate mouse NGF as well as to stain by immunohistochemical methods cellular sites of NGF synthesis. Increased levels of anti-NGF antibodies were found in sera of herpes simplex virus (HSV)-infected patients but not in HSV-inoculated rabbits. As HSV latency is known to be promoted by NGF in vitro, these results may suggest that anti-NGF antibodies modulate the cytokine function of NGF and thus might play a role in HSV infection. The biological function of circulating antibodies against NGF, in general, is now open to future investigation.     

不同分级肝硬化患者血清甲状腺素水平的意义

目的探讨肝硬化患者血清中甲状腺素水平的变化与肝硬化病变程度及其临床实验室检查之间的相关性。方法用放免法测定肝硬化患者血清FT3、FT4、PC-Ⅲ、Ⅳ-C、LN及HA，并按Child—Pugh方法将肝功能分为A、B、C三级。结果随着肝硬化病变程度的加重，血清肝纤维化指标逐渐增高，甲状腺素呈下降趋势，同时血清甲状腺素水平与肝硬化的低蛋白血症、腹水及凝血酶原时间密切相关。结论肝硬化患者体内存在不同程度的甲状腺素水平紊乱，紊乱程度与肝功能受损程度有明显相关性，联合检测血清FT3、FT4、PC-Ⅲ、Ⅳ—C、LN及HA对估计肝硬化病变程度及判断预后有十分重要的临床价值。